Plexin D1: New potential biomarker for cervical cancer

Journal of Immunoassay and Immunochemistry

Volumn 33, Issue 3, 2012, Pages 223-233

  Shalaby, Manal Aly ^a   Hampson, Lynne ^b   Oliver, Anthony ^b   Hampson, Ian ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

angiogenesis; biomarker; cervical cancer; immunohistochemistry; plexin D1

Indexed keywords

PLEXIN; PLEXIN D1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER;

ADULT; AGED; CELL ADHESION MOLECULES, NEURONAL; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84863500002     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2011.634472     Document Type: Article

References (19)

1. Yancopoulos, G. D.; Davis, S.; Gale, N. W.; Rudge, J. S.; Wiegand, S. J.; Holash, J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407(6801), 242-248.
2. Zetter, B. R. Angiogenesis and tumor metastasis. Annu. Rev. Med. 1998, 49, 407-424.
3. Cantu De Leon, D.; Lopez-Graniel, C.; Frias Mendivil, M.; Chanona Vilchis, G.; Gomez, C.; De La Garza Salazar, J. Significance of microvascular density (MVD) in cervical cancer recurrence. Int. J. Gynecol. Cancer 2003, 13(6), 856-862.
4. Roodink, I.; Raats, J.; van der Zwaag, B.; Verrijp, K.; Kusters, B.; van Bokhoven, H.; Linkels, M.; de Waal, R. M.; Leenders, W. P. Plexin D1 expression is induced on tumor vasculature and tumor cells: A novel target for diagnosis and therapy?. Cancer Res. 2005, 65(18), 8317-8323.
5. Bonner, J.; O'Connor, T. P. Semaphorin function in the developing invertebrate peripheral nervous system. Biochem. Cell Biol. 2000, 78(5), 603-611.
6. Guttmann-Raviv, N.; Shraga-Heled, N.; Varshavsky, A.; Guimaraes-Sternberg, C.; Kessler, O.; Neufeld, G. Semaphorin-3A and semaphorin-3 F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem. 2007, 282(36), 26294-26305.
7. Liang, W. C.; Dennis, M. S.; Stawicki, S.; Chanthery, Y.; Pan, Q.; Chen, Y.; Eigenbrot, C.; Yin, J.; Koch, A. W.; Wu, X.; Ferrara, N.; Bagri, A.; Tessier-Lavigne, M.; Watts, R. J.; Wu, Y. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J Mol Biol. 2007, 366(3), 815-829.
8. Basile, J. R.; Afkhami, T.; Gutkind, J. S. Semaphorin 4D=Plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol. Cell. Biol. 2005, 25(16), 6889-6898.
9. Gu, C.; Yoshida, Y.; Livet, J.; Reimert, D. V.; Mann, F.; Merte, J.; Henderson, C. E.; Jessell, T. M.; Kolodkin, A. L.; Ginty, D. D. Semaphorin 3E and Plexin-D1 control vascular pattern independently of neuropilins. Science 2005, 307(5707), 265-268.
10. van der Zwaag, B.; Hellemons, A. J.; Leenders, W. P.; Burbach, J. P.; Brunner, H. G.; Padberg, G. W.; Van Bokhoven, H. PLEXIN-D1, a novel plexin family member, is expressed in vascular endothelium and the central nervous system during mouse embryogenesis. Dev. Dyn. 2002, 225(3), 336-343.
11. Carmeliet, P.; Tessier-Lavigne, M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436(7048), 193-200.
12. Roodink, I.; Kats, G.; van Kempen, L.; Grunberg, M.; Maass, C.; Verrijp, K.; Raats, J.; Leenders, W. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression. Am. J. Pathol. 2008, 173(6), 1873-1881.
13. Christensen, C. R.; Klingelhofer, J.; Tarabykina, S.; Hulgaard, E. F.; Kramerov, D.; Lukanidin, E. Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res. 1998, 58(6), 1238-1244.
14. Shalaby, M.; Hampson, L.; Oliver, A.; Hampson, I. Identification of PlexinD1 and AHDC1 as a putative interactors for Tip-1 protein. Genes and Genomics 2011, 33, 399-405.
15. Oliver, A. W.; He, X.; Borthwick, K.; Donne, A. J.; Hampson, L.; Hampson, I. N. The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br. J. Cancer 104(2), 324-331.
16. Roodink, I.; Verrijp, K.; Raats, J.; Leenders, W. P. Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. BMC Cancer 2009, 9, 297-306.
17. Kusters, B.; de Waal, R. M.; Wesseling, P.; Verrijp, K.; Maass, C.; Heerschap, A.; Barentsz, J. O.; Sweep, F.; Ruiter, D. J.; Leenders, W. P. Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma. Cancer Res. 2003, 63(17), 5408-5413.
18. Banerjee, M.; Huang, C.; Marquez, J.; Mohanty, S. Probing the structure and function of human glutaminase-interacting protein: a possible target for drug design. Biochemistry 2008, 47(35), 9208-9219.
19. Salomaki, H. H.; Sainio, A. O.; Soderstrom, M.; Pakkanen, S.; Laine, J.; Jarvelainen, H. T. Differential expression of decorin by human malignant and benign vascular tumors. J. Histochem. Cytochem. 2008, 56(7), 639-646.